ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 19 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $483 | +4.1% | 933,000 | 0.0% | 0.02% | +4.5% |
Q2 2023 | $464 | +5.0% | 933,000 | -4.6% | 0.02% | -4.3% |
Q1 2023 | $442 | -4.3% | 978,000 | +15.3% | 0.02% | -8.0% |
Q4 2022 | $462 | -99.9% | 848,000 | 0.0% | 0.02% | -3.8% |
Q3 2022 | $473,000 | +0.9% | 848,000 | 0.0% | 0.03% | +4.0% |
Q2 2022 | $469,000 | +5.6% | 848,000 | -2.3% | 0.02% | +25.0% |
Q1 2022 | $444,000 | -3.7% | 868,000 | -1.7% | 0.02% | -4.8% |
Q4 2021 | $461,000 | – | 883,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 18,764 | $9,907,000 | 0.77% |
Pentwater Capital Management LP | 46,411,000 | $24,770,000 | 0.27% |
WHITEBOX ADVISORS LLC | 22,500,000 | $11,756,000 | 0.24% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $10,993,000 | 0.23% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,590,000 | $9,286,000 | 0.20% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 24,000,000 | $12,540,000 | 0.18% |
BlueCrest Capital Management Ltd | 7,000,000 | $3,705,000 | 0.12% |
DCF Advisers, LLC | 400,000 | $211,000 | 0.09% |
Walleye Capital LLC | 5,000 | $2,638,000 | 0.08% |
INGALLS & SNYDER LLC | 883,000 | $461,000 | 0.02% |